Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphedema × pycnogenols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Menorrhagia 1 Lymphedema 1

Interventions

Exercise 10 Manual Lymphatic Drainage 9 Low-Level Light Therapy 6 Standard of Care 4 Physical Therapy Modalities 4 Exercise Therapy 4 Surveys and Questionnaires 3 Resistance Training 3 Methods 3 Lipectomy 3 Acupuncture Therapy 3 Yoga 2 Technetium Tc 99m Sulfur Colloid 2 Restraint, Physical 2 Radiotherapy 2 Ketoprofen 2 Indocyanine Green 2 High-Energy Shock Waves 2 Early Intervention, Educational 2 Bupivacaine 2 Bevacizumab 2 specific substance maruyama 1 pycnogenols 1 pazopanib 1 carbohydrate-deficient transferrin 1 Weights and Measures 1 Weight Reduction Programs 1 Ultrasonography 1 Triamcinolone 1 Transplantation, Autologous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00214032 2015-10-05

Pycnogenol for the Treatment of Lymphedema

University of Wisconsin, Madison

Phase 2 Completed

Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡